Your browser doesn't support javascript.
loading
Characterization of SHARPIN knockout Syrian hamsters developed using CRISPR/Cas9 system.
Miao, Jinxin; Lan, Tianfeng; Guo, Haoran; Wang, Jianyao; Zhang, Guangtao; Wang, Zheng; Yang, Panpan; Li, Haoze; Zhang, Chunyang; Wang, Yaohe; Li, Xiu-Min; Miao, Mingsan.
Afiliação
  • Miao J; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
  • Lan T; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Guo H; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang J; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Zhang G; Department of Oncology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
  • Wang Z; Academy of Chinese Medicine Science, Henan University of Chinese Medicine, Zhengzhou, Henan, People's Republic of China.
  • Yang P; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li H; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Zhang C; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Wang Y; Department of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
  • Li XM; Department of General Thoracic Surgery, Hami Central Hospital, Hami, Xinjiang, People's Republic of China.
  • Miao M; Sino-British Research Center for Molecular Oncology, National Center for the International Research in Cell and Gene Therapy, School of Basic Sciences, Academy of Medical Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China.
Animal Model Exp Med ; 6(5): 489-498, 2023 10.
Article em En | MEDLINE | ID: mdl-36097701
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: NF-kappa B / Sistemas CRISPR-Cas Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: NF-kappa B / Sistemas CRISPR-Cas Limite: Animals Idioma: En Ano de publicação: 2023 Tipo de documento: Article